Real-world long-term treatment persistence among bio-na Ïve patients with crohn’s disease and history of fistula initiated on ustekinumab

This study described long-term persistence among bio-naïve patients with CD and history of fistula who were initiated on ustekinumab (anti-interleukin 12/23 antibody).

Source: Gastroenterology - January 25, 2024 Category: Gastroenterology Authors: Maryia Zhdanava, Sumesh Kachroo, Porpong Boonmak, Sabree Burbage, Aditi Shah, Zhuohan Jiang, Patrick Lefebvre, Caroline Kerner, Dominic Pilon Source Type: research